News
CMS expands AI-assisted prior authorization review inside Original Medicare to six states
CMS is piloting AI/ML-assisted review of prior-authorization requests inside Original Medicare across six states, targeting a pre-selected list of services flagged as high-volume and fraud-prone. The pilot, which launched in early 2026, uses AI to flag requests that match approval patterns for fast-track processing and requests with anomalous characteristics for enhanced human review — a two-track approach designed to reduce administrative burden while improving fraud detection.
- CMS
- prior-authorization
- Medicare
- AI-review
- fraud-detection
- administrative-burden
CMS’s prior-authorization AI pilot inside Original Medicare is structurally different from what commercial insurers have been doing with algorithmic prior-authorization for years. The commercial insurer use case — which generated a wave of lawsuits and Congressional attention in 2024–2025 — involved AI models making or heavily influencing denial decisions. CMS’s pilot is using AI as a triage tool: categorizing requests by approval likelihood and routing them appropriately, with humans making all actual approval or denial decisions.
That design choice is important and probably politically deliberate. CMS is operating in the aftermath of regulatory action against UnitedHealth Group’s nH Predict algorithm and the Congressional pressure that followed. The two-track AI-triage approach (fast-track likely approvals, flag anomalies for human review) is defensible in a way that AI-generated denials without human review are not.
The six-state pilot footprint creates a natural comparison group. CMS should be generating data on turnaround time, denial rates, appeal rates, and administrative cost in the pilot states versus comparators. That data will be decisive for whether the pilot scales nationally — and it will also be subpoenaed or FOIA’d by both industry and advocacy groups, so the quality of the evidence matters.
For provider organizations in the six pilot states, the operational question is whether AI-triage approval pathways are actually faster in practice, and whether the “anomalous request” flagging generates inappropriate enhanced-review burdens for certain provider types or patient populations.
Primary source: Read the full original on blueBriX Health ↗